Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
494.9 USD | +0.83% |
|
+1.84% | +21.64% |
12:55pm | Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $589 From $577, Maintains Buy Rating | MT |
Jul. 15 | Vertex Sues U.S. to Pay for Fertility Treatments | DJ |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.30% | 127B | |
+24.12% | 117B | |
+26.26% | 27.67B | |
-18.91% | 20.33B | |
-15.87% | 16.79B | |
-18.38% | 15.63B | |
+13.57% | 14.84B | |
-47.70% | 14.65B | |
+57.97% | 14.43B | |
+149.61% | 12.49B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $589 From $577, Maintains Buy Rating